Skip to main content
Erschienen in: Heart and Vessels 5/2019

20.11.2018 | Original Article

Residual high intrapulmonary shunt fraction limits exercise capacity in patients treated with balloon pulmonary angioplasty

verfasst von: Makoto Takei, Takashi Kawakami, Masaharu Kataoka, Ichiro Kuwahira, Keiichi Fukuda

Erschienen in: Heart and Vessels | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Balloon pulmonary angioplasty (BPA) has emerged as a new treatment strategy for patients with chronic thromboembolic pulmonary hypertension (CTEPH). Improvements in hemodynamic parameters after BPA have been reported, but some patients continue to suffer from reduced exercise tolerance even after the normalization of hemodynamic parameters following BPA. As the amelioration of hemodynamic parameters is reportedly achieved via BPA, we hypothesized that the limiting factors for exercise tolerance in these patients are related to respiratory function. Therefore, we investigated the associations between respiratory function and exercise tolerance, and the mechanisms underlying respiratory dysfunction in patients after BPA. We analyzed 62 patients with CTEPH who underwent 1-year follow-up after BPA. Predictors for reduced exercise tolerance after BPA determined with six-minute walk test were sought from pulmonary hemodynamic and respiratory parameters using logistic regression analysis. After multivariate adjustments, high mean right atrium pressure (mRAP) and high alveolar-arterial oxygen gradient (A-aDO2) were significant predictors for reduced exercise tolerance. Next, we analyzed factors associated with high A-aDO2. Among the pathophysiological causes of high A-aDO2, including ventilation, diffusing capacity, and low ventilation-perfusion ratio, only low ventilation-perfusion ratio caused by high intrapulmonary shunt fraction was associated with high A-aDO2. Impaired oxygenation due to residual high intrapulmonary shunt fraction was associated with reduced exercise tolerance in patients with CTEPH, after receiving BPA.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G, ESC Committee for Practive Guidelines (CPG) (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30(20):2493–2537CrossRefPubMed Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G, ESC Committee for Practive Guidelines (CPG) (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30(20):2493–2537CrossRefPubMed
2.
Zurück zum Zitat Piazza G, Goldhaber SZ (2011) Chronic thromboembolic pulmonary hypertension. N Engl J Med 364(4):351–360CrossRefPubMed Piazza G, Goldhaber SZ (2011) Chronic thromboembolic pulmonary hypertension. N Engl J Med 364(4):351–360CrossRefPubMed
3.
Zurück zum Zitat Kataoka M, Inami T, Hayashida K, Shimura N, Ishiguro H, Abe T, Tamura Y, Ando M, Fukuda K, Yoshino H, Satoh T (2012) Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 5(6):756–762CrossRefPubMed Kataoka M, Inami T, Hayashida K, Shimura N, Ishiguro H, Abe T, Tamura Y, Ando M, Fukuda K, Yoshino H, Satoh T (2012) Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 5(6):756–762CrossRefPubMed
4.
Zurück zum Zitat Mizoguchi H, Ogawa A, Munemasa M, Mikouchi H, Ito H, Matsubara H (2012) Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 5(6):748–755CrossRefPubMed Mizoguchi H, Ogawa A, Munemasa M, Mikouchi H, Ito H, Matsubara H (2012) Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 5(6):748–755CrossRefPubMed
5.
Zurück zum Zitat Tsugu T, Murata M, Kawakami T, Yasuda R, Tokuda H, Minakata Y, Tamura Y, Kataoka M, Hayashida K, Tsuruta H, Maekawa Y, Inoue S, Fukuda K (2015) Significance of echocardiographic assessment for right ventricular function after balloon pulmonary angioplasty in patients with chronic thromboembolic induced pulmonary hypertension. Am J Cardiol 115(2):256–261CrossRefPubMed Tsugu T, Murata M, Kawakami T, Yasuda R, Tokuda H, Minakata Y, Tamura Y, Kataoka M, Hayashida K, Tsuruta H, Maekawa Y, Inoue S, Fukuda K (2015) Significance of echocardiographic assessment for right ventricular function after balloon pulmonary angioplasty in patients with chronic thromboembolic induced pulmonary hypertension. Am J Cardiol 115(2):256–261CrossRefPubMed
6.
Zurück zum Zitat Kawakami T, Kataoka M, Arai T, Yanagisawa R, Maekawa Y, Fukuda K (2016) Retrograde approach in balloon pulmonary angioplasty: useful novel strategy for chronic total occlusion lesions in pulmonary arteries. JACC Cardiovasc Interv 9(2):e19–e20CrossRefPubMed Kawakami T, Kataoka M, Arai T, Yanagisawa R, Maekawa Y, Fukuda K (2016) Retrograde approach in balloon pulmonary angioplasty: useful novel strategy for chronic total occlusion lesions in pulmonary arteries. JACC Cardiovasc Interv 9(2):e19–e20CrossRefPubMed
7.
Zurück zum Zitat Kawakami T, Kataoka M, Yamada Y, Takei M, Yamada M, Jinzaki M, Fukuda K (2015) Impact of CT-guided balloon pulmonary angioplasty with identification of pulmonary arterial structures distal to target lesions. EuroIntervention 11(7):e1–e2CrossRefPubMed Kawakami T, Kataoka M, Yamada Y, Takei M, Yamada M, Jinzaki M, Fukuda K (2015) Impact of CT-guided balloon pulmonary angioplasty with identification of pulmonary arterial structures distal to target lesions. EuroIntervention 11(7):e1–e2CrossRefPubMed
8.
Zurück zum Zitat American Thoracic Society (1995) Standardization of spirometry 1994 update. Am J Respir Crit Care Med 152(3):1107–1136CrossRef American Thoracic Society (1995) Standardization of spirometry 1994 update. Am J Respir Crit Care Med 152(3):1107–1136CrossRef
9.
Zurück zum Zitat West JB (1995) Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique—1995 update. Am J Respir Crit Care Med 152(6 Pt 1):2185–2198 West JB (1995) Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique—1995 update. Am J Respir Crit Care Med 152(6 Pt 1):2185–2198
10.
Zurück zum Zitat West JB (2012) Respiratory physiology: the essentials. Lippincott Williams & Wilkins, Philadelphia, pp 36–56 West JB (2012) Respiratory physiology: the essentials. Lippincott Williams & Wilkins, Philadelphia, pp 36–56
11.
Zurück zum Zitat Austrap P, Severinghaus JW (1986) The history of blood gases, acids and bases, 1st edn. Munksgaard, Copenhagen, pp 128–156 Austrap P, Severinghaus JW (1986) The history of blood gases, acids and bases, 1st edn. Munksgaard, Copenhagen, pp 128–156
12.
Zurück zum Zitat Puente-Maestu L, Palange P, Casaburi R, Laveneziana P, Maltais F, Neder JA, O'Donnell DE, Onorati P, Porszasz J, Rabinovich R, Rossiter HB, Singh S, Troosters T, Ward S (2016) Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement. Eur Respir J 47(2):429–460CrossRefPubMed Puente-Maestu L, Palange P, Casaburi R, Laveneziana P, Maltais F, Neder JA, O'Donnell DE, Onorati P, Porszasz J, Rabinovich R, Rossiter HB, Singh S, Troosters T, Ward S (2016) Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement. Eur Respir J 47(2):429–460CrossRefPubMed
13.
Zurück zum Zitat Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M, Aboyans V, Vaz Carneiro A, Achenbach S, Agewall S, Allanore Y, Asteggiano R, Paolo Badano L, Albert Barbera J, Bouvaist H, Bueno H, Byrne RA, Carerj S, Castro G, Erol C, Falk V, Funck-Brentano C, Gorenflo M, Granton J, Iung B, Kiely DG, Kirchhof P, Kjellstrom B, Landmesser U, Lekakis J, Lionis C, Lip GY, Orfanos SE, Park MH, Piepoli MF, Ponikowski P, Revel MP, Rigau D, Rosenkranz S, Voller H, Luis Zamorano J (2016) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37(1):67–119CrossRefPubMed Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M, Aboyans V, Vaz Carneiro A, Achenbach S, Agewall S, Allanore Y, Asteggiano R, Paolo Badano L, Albert Barbera J, Bouvaist H, Bueno H, Byrne RA, Carerj S, Castro G, Erol C, Falk V, Funck-Brentano C, Gorenflo M, Granton J, Iung B, Kiely DG, Kirchhof P, Kjellstrom B, Landmesser U, Lekakis J, Lionis C, Lip GY, Orfanos SE, Park MH, Piepoli MF, Ponikowski P, Revel MP, Rigau D, Rosenkranz S, Voller H, Luis Zamorano J (2016) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37(1):67–119CrossRefPubMed
14.
Zurück zum Zitat Yanagisawa R, Kataoka M, Inami T, Shimura N, Ishiguro H, Fukuda K, Yoshino H, Satoh T (2014) Safety and efficacy of percutaneous transluminal pulmonary angioplasty in elderly patients. Int J Cardiol 175(2):285–289CrossRefPubMed Yanagisawa R, Kataoka M, Inami T, Shimura N, Ishiguro H, Fukuda K, Yoshino H, Satoh T (2014) Safety and efficacy of percutaneous transluminal pulmonary angioplasty in elderly patients. Int J Cardiol 175(2):285–289CrossRefPubMed
15.
Zurück zum Zitat Inami T, Kataoka M, Yanagisawa R, Ishiguro H, Shimura N, Fukuda K, Yoshino H, Satoh T (2016) Long-term outcomes after percutaneous transluminal pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Circulation 134(24):2030–2032CrossRefPubMed Inami T, Kataoka M, Yanagisawa R, Ishiguro H, Shimura N, Fukuda K, Yoshino H, Satoh T (2016) Long-term outcomes after percutaneous transluminal pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Circulation 134(24):2030–2032CrossRefPubMed
16.
Zurück zum Zitat Aoki T, Sugimura K, Nochioka K, Miura M, Tatebe S, Yamamoto S, Yaoita N, Suzuki H, Sato H, Kozu K, Miyata S, Satoh K, Shimokawa H (2016) Effects of balloon pulmonary angioplasty on oxygenation in patients with chronic thromboembolic pulmonary hypertension- importance of intrapulmonary shunt. Circ J 80(10):2227–2234CrossRefPubMed Aoki T, Sugimura K, Nochioka K, Miura M, Tatebe S, Yamamoto S, Yaoita N, Suzuki H, Sato H, Kozu K, Miyata S, Satoh K, Shimokawa H (2016) Effects of balloon pulmonary angioplasty on oxygenation in patients with chronic thromboembolic pulmonary hypertension- importance of intrapulmonary shunt. Circ J 80(10):2227–2234CrossRefPubMed
Metadaten
Titel
Residual high intrapulmonary shunt fraction limits exercise capacity in patients treated with balloon pulmonary angioplasty
verfasst von
Makoto Takei
Takashi Kawakami
Masaharu Kataoka
Ichiro Kuwahira
Keiichi Fukuda
Publikationsdatum
20.11.2018
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 5/2019
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-018-1306-2

Weitere Artikel der Ausgabe 5/2019

Heart and Vessels 5/2019 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.